Temat: "HIV" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Performance evaluation of the new Access HIV Ag/Ab combo assay on the DxI 9000 Access Immunoassay Analyzer.
Autorzy:: Lemée V; CHU Rouen, Department of Virology, National Reference Center of HIV, F-76000 Rouen, France; Univ Rouen Normandie, Univ de Caen, INSERM, DYNAMICURE UMR 1311, CHU Rouen, Department of Virology, National Reference Center of HIV, F-76000 Rouen, France.
Gréaume S; Etablissement Français du Sang (EFS) Hauts-de-France - Normandie (HFNO), Bois Guillaume, France.
Gautier J; Cerba Xpert, Cergy-Pontoise, France.
Dzamitika SA; Cerba Xpert, Cergy-Pontoise, France.
Coignard C; Eurofins Biomnis, Ivry-sur-Seine, France.
Jortani SA; Kentucky Clinical Trials Laboratory (KCTL), Louisville, KY, USA; University of Louisville School of Medicine, Louisville, KY, USA.
Grillet B; Beckman Coulter Immunotech, Marseille, France.
Badawi M; Beckman Coulter Immunotech, Marseille, France.
Plantier JC; CHU Rouen, Department of Virology, National Reference Center of HIV, F-76000 Rouen, France; Univ Rouen Normandie, Univ de Caen, INSERM, DYNAMICURE UMR 1311, CHU Rouen, Department of Virology, National Reference Center of HIV, F-76000 Rouen, France. Electronic address: .; Pokaż więcej
Źródło:: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2024 Oct; Vol. 174, pp. 105712. Date of Electronic Publication: 2024 Jul 07.
Typ publikacji:: Journal Article; Evaluation Study; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: HIV Infections*/diagnosis
Sensitivity and Specificity*
HIV Antibodies*/blood
HIV-1*/immunology
HIV-1*/genetics
HIV Core Protein p24*/blood
HIV Core Protein p24*/immunology
Humans ; Immunoassay/methods ; HIV Antigens/blood ; HIV Antigens/immunology ; HIV-2/immunology ; HIV-2/genetics ; Reagent Kits, Diagnostic/standards

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 2.

Tytuł:: Host urinary biomarkers in HIV positive and HIV negative patients with tubercular uveitis and other uveitic diseases.
Autorzy:: van der Westhuizen DP; Division of Ophthalmology, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa. Electronic address: .
Snyders CI; South African Medical Research Council Centre for Tuberculosis Research, Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa. Electronic address: .
Kidd M; Centre for Statistical Consultation, Stellenbosch University, Private Bag X1, Matieland, 7602, South Africa. Electronic address: .
Walzl G; South African Medical Research Council Centre for Tuberculosis Research, Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa. Electronic address: .
Chegou NN; South African Medical Research Council Centre for Tuberculosis Research, Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa. Electronic address: .
Smit DP; Division of Ophthalmology, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa. Electronic address: .; Pokaż więcej
Źródło:: Tuberculosis (Edinburgh, Scotland) [Tuberculosis (Edinb)] 2024 Sep; Vol. 148, pp. 102547. Date of Electronic Publication: 2024 Jul 23.
Typ publikacji:: Journal Article; Comparative Study
MeSH Terms:: Biomarkers*/urine
Uveitis*/urine
Uveitis*/microbiology
Uveitis*/diagnosis
Tuberculosis, Ocular*/urine
Tuberculosis, Ocular*/diagnosis
HIV Infections*/urine
HIV Infections*/complications
Humans ; Male ; Female ; Adult ; Middle Aged ; Coinfection/urine ; Diagnosis, Differential ; HIV Seropositivity/urine ; HIV Seropositivity/complications ; HIV Seronegativity ; Young Adult ; Predictive Value of Tests ; Urinalysis/methods

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 3.

Tytuł:: Seronegative HIV-1 infection in a Japanese man presenting with Pneumocystis pneumonia: Analysis of long-term antibody response and literature review.
Autorzy:: Seto N; Division of General Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Fukuchi T; Division of General Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Kawakami M; Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Nagashima M; Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Sadamasu K; Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
Hatakeyama S; Division of Infectious Diseases, Department of Infection and Immunity, Jichi Medical University, Tochigi, Japan; Division of General Medicine, Center for Community Medicine, Jichi Medical University, Tochigi, Japan. Electronic address: .; Pokaż więcej
Źródło:: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Sep; Vol. 30 (9), pp. 917-921. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:: Case Reports; Journal Article; Review
MeSH Terms:: Pneumonia, Pneumocystis*/diagnosis
Pneumonia, Pneumocystis*/immunology
Pneumonia, Pneumocystis*/microbiology
HIV-1*/immunology
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/immunology
Humans ; Male ; Middle Aged ; HIV Antibodies/blood ; HIV Antibodies/immunology ; Viral Load ; AIDS-Related Opportunistic Infections/diagnosis ; AIDS-Related Opportunistic Infections/immunology ; AIDS-Related Opportunistic Infections/microbiology ; HIV Seronegativity ; Antibody Formation ; Pneumocystis carinii/isolation & purification ; Pneumocystis carinii/immunology ; East Asian People

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 4.

Tytuł:: Performance of a rapid recency assay for detection of early HIV infection.
Autorzy:: Di Germanio C; Vitalant Research Institute, San Francisco, USA; Department of Laboratory Medicine, University of California, San Francisco, USA. Electronic address: .
Deng X; Vitalant Research Institute, San Francisco, USA; Department of Laboratory Medicine, University of California, San Francisco, USA.
Grebe E; Vitalant Research Institute, San Francisco, USA; Department of Laboratory Medicine, University of California, San Francisco, USA.
Johnson JA; Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, USA.
Masciotra S; Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, USA.
Busch MP; Vitalant Research Institute, San Francisco, USA; Department of Laboratory Medicine, University of California, San Francisco, USA.
Norris PJ; Vitalant Research Institute, San Francisco, USA; Department of Laboratory Medicine, University of California, San Francisco, USA.; Pokaż więcej
Źródło:: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2024 Oct; Vol. 174, pp. 105708. Date of Electronic Publication: 2024 Jun 22.
Typ publikacji:: Journal Article; Evaluation Study; Research Support, Non-U.S. Gov't
MeSH Terms:: HIV Infections*/diagnosis
HIV-1*/isolation & purification
HIV-1*/immunology
HIV-1*/genetics
Humans ; Sensitivity and Specificity ; Male ; HIV Antibodies/blood ; Adult ; Female ; Early Diagnosis ; Nucleic Acid Amplification Techniques/methods ; Time Factors ; HIV Testing/methods ; Middle Aged ; Reagent Kits, Diagnostic/standards ; Molecular Diagnostic Techniques/methods ; Molecular Diagnostic Techniques/standards

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 5.

Tytuł:: TAR RNA selective targeting ruthenium(II) complexes as HIV-1 reverse transcriptase inhibitors: On exploring structure-activity relationships of multiple positions.
Autorzy:: Liu M; Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650050, PR China.
Xie DD; Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650050, PR China.
Guo YX; Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650050, PR China.
Zhao RY; Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650050, PR China.
Liu FD; Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650050, PR China.
Zhang H; Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650050, PR China.
Gao F; Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650050, PR China. Electronic address: .; Pokaż więcej
Źródło:: Journal of inorganic biochemistry [J Inorg Biochem] 2024 Oct; Vol. 259, pp. 112664. Date of Electronic Publication: 2024 Jul 15.
Typ publikacji:: Journal Article
MeSH Terms:: Ruthenium*/chemistry
HIV-1*/drug effects
HIV-1*/enzymology
HIV Reverse Transcriptase*/antagonists & inhibitors
HIV Reverse Transcriptase*/metabolism
HIV Reverse Transcriptase*/chemistry
Reverse Transcriptase Inhibitors*/pharmacology
Reverse Transcriptase Inhibitors*/chemistry
Coordination Complexes*/pharmacology
Coordination Complexes*/chemistry
RNA, Viral*/metabolism
Humans ; Structure-Activity Relationship ; Anti-HIV Agents/pharmacology ; Anti-HIV Agents/chemistry ; HIV Long Terminal Repeat/drug effects

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 6.

Tytuł:: New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs.
Autorzy:: Marra M; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, Italy.
Catalano A; Department of Pharmacy-Drug Sciences, University of Bari 'Aldo Moro', 70126 Bari, Italy.
Sinicropi MS; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, Italy.
Ceramella J; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, Italy.
Iacopetta D; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, Italy.
Salpini R; Department of Experimental Medicine, University of Tor Vergata, 00133 Rome, Italy.
Svicher V; Department of Experimental Medicine, University of Tor Vergata, 00133 Rome, Italy.
Marsico S; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, Italy.
Aquaro S; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, Italy.
Pellegrino M; Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Via Pietro Bucci, 87036 Arcavacata di Rende, Italy.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Sep 18; Vol. 16 (9). Date of Electronic Publication: 2024 Sep 18.
Typ publikacji:: Journal Article; Review
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/virology
Macrophages*/virology
Macrophages*/drug effects
Virus Latency*/drug effects
HIV-1*/drug effects
HIV-1*/physiology
Humans ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/pharmacology ; Antiretroviral Therapy, Highly Active ; Disease Reservoirs/virology ; Virus Replication/drug effects ; Animals

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 study.
Autorzy:: De Nicolò A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin. Electronic address: .
Palermiti A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin.
Dispinseri S; Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele, Milan.
Marchetti G; Clinic of Infectious Diseases, Department of Health Sciences, ASST Santi Paolo e Carlo, University of Milan, Milan.
Trunfio M; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin.
De Vivo E; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin.
D'Avolio A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin.
Muscatello A; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan.
Gori A; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan.
Rusconi S; UOC Malattie Infettive, Ospedale Civile di Legnano, ASST Ovest Milanese, Legnano; University of Milan, Milan.
Bruzzesi E; Vita-Saluta San Raffaele University, Milan.
Gabrieli A; Dipartimento di Scienze Biomediche e Cliniche, Ospedale L Sacco, Milan.
Bernasconi DP; Bicocca Bioinformatics Biostatistics and Bioimaging Centre - B4 School of Medicine and Surgery, University of Milano-Bicocca, Monza.
Bandera A; University of Milan, Milan.
Nozza S; Department of Infectious Diseases, IRCCS Ospedale san Raffaele, Milan, Italy.
Calcagno A; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin.; Pokaż więcej
Corporate Authors:: INACTION (Italian Network of Acute HIV Infection) study group
Źródło:: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Aug; Vol. 64 (2), pp. 107200. Date of Electronic Publication: 2024 May 18.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/virology
DNA, Viral*/blood
Leukocytes, Mononuclear*/virology
Lymph Nodes*/virology
Tenofovir*/therapeutic use
Tenofovir*/pharmacokinetics
Tenofovir*/blood
Humans ; Male ; Adult ; Female ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/pharmacokinetics ; Anti-HIV Agents/blood ; Oxazines ; Middle Aged ; RNA, Viral/blood ; Plasma/chemistry ; Plasma/virology ; Piperazines/blood ; Emtricitabine/therapeutic use ; Emtricitabine/pharmacokinetics ; Emtricitabine/blood ; Heterocyclic Compounds, 3-Ring/pharmacokinetics ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Heterocyclic Compounds, 3-Ring/blood ; Pyridones/therapeutic use ; Darunavir/therapeutic use ; Darunavir/pharmacokinetics ; Darunavir/blood ; HIV-1/drug effects ; Viral Load ; Alanine/blood ; Anti-Retroviral Agents/therapeutic use ; Anti-Retroviral Agents/pharmacokinetics ; Anti-Retroviral Agents/blood

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 8.

Tytuł:: The Impact of COVID-19 on the HIV Cascade of Care in Botswana - An Interrupted Time Series.
Autorzy:: Sehurutshi A; Division of Epidemiology and Biostatistics, Stellenbosch University, Cape Town, South Africa.; Harvard AIDS Institute Partnership, Gaberone, Botswana.
Farooqui H; Department of Population Medicine, College of Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
Chivese T; Department of Population Medicine, College of Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar. .; Pokaż więcej
Źródło:: AIDS and behavior [AIDS Behav] 2024 Aug; Vol. 28 (8), pp. 2630-2638. Date of Electronic Publication: 2024 Jun 10.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
COVID-19*/prevention & control
HIV Infections*/epidemiology
Interrupted Time Series Analysis*
SARS-CoV-2*
Humans ; Botswana/epidemiology ; Male ; Female ; Adult ; Middle Aged ; HIV Testing/statistics & numerical data ; Young Adult ; Anti-HIV Agents/therapeutic use ; Pandemics

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 9.

Tytuł:: Direct whole-genome sequencing of HIV-1 for clinical drug-resistance analysis and public health surveillance.
Autorzy:: Coldbeck-Shackley RC; Microbiology and Infectious Diseases, SA Pathology, Adelaide 5000 Australia. Electronic address: .
Adamson PJ; Microbiology and Infectious Diseases, SA Pathology, Adelaide 5000 Australia.
Whybrow D; Microbiology and Infectious Diseases, SA Pathology, Adelaide 5000 Australia.
Selway CA; Microbiology and Infectious Diseases, SA Pathology, Adelaide 5000 Australia.
Papanicolas LE; Microbiology and Infectious Diseases, SA Pathology, Adelaide 5000 Australia.
Turra M; Microbiology and Infectious Diseases, SA Pathology, Adelaide 5000 Australia.
Leong LEX; Microbiology and Infectious Diseases, SA Pathology, Adelaide 5000 Australia; UniSA Clinical and Health Sciences, University of South Australia, Adelaide 5000 Australia.; Pokaż więcej
Źródło:: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2024 Oct; Vol. 174, pp. 105709. Date of Electronic Publication: 2024 Jun 21.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: HIV-1*/genetics
HIV-1*/drug effects
HIV-1*/classification
Drug Resistance, Viral*/genetics
HIV Infections*/virology
HIV Infections*/drug therapy
Whole Genome Sequencing*/methods
Phylogeny*
Genotype*
Genome, Viral*
Humans ; Public Health Surveillance ; Anti-HIV Agents/pharmacology ; Anti-HIV Agents/therapeutic use ; pol Gene Products, Human Immunodeficiency Virus/genetics

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 10.

Tytuł:: Risk of tuberculosis after initiation of antiretroviral therapy among persons with HIV in Europe.
Autorzy:: Johansen IS; Department of Infectious Diseases, Odense University Hospital, University of Southern Denmark, Odense, Denmark; Research Unit of Infectious Diseases, Department of Clinical Research, University of Southern Denmark, Odense, Denmark. Electronic address: .
Roen A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Kraef C; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Martín-Iguacel R; Department of Infectious Diseases, Odense University Hospital, University of Southern Denmark, Odense, Denmark; Research Unit of Infectious Diseases, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Nemeth J; Swiss HIV Cohort Study (SHCS), University of Zurich, Zurich, Switzerland.
Fenner L; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Zangerle R; Austrian HIV Cohort Study (AHIVCOS), Medizinische Universität Innsbruck, Innsbruck, Austria.
Llibre JM; Infectious Diseases Division, University Hospital Germans Trias, Badalona, Spain; Fight Infections Foundation, Badalona, Spain.
Miller RF; The Royal Free HIV Cohort Study, Royal Free Hospital, University College London, London, UK.
Suarez I; Department of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany.
de Wit S; CHU Saint-Pierre, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium.
Wit F; AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort, HIV Monitoring Foundation, Amsterdam, the Netherlands.
Mussini C; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy.
Saracino A; Italian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milano, Italy.
Canetti D; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy.
Volny-Anne A; European AIDS Treatment Group (EATG), Brussels, Belgium.
Jaschinski N; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Neesgaard B; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Ryom L; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Dept of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Peters L; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Garges HP; ViiV Healthcare, RTP, NC, USA.
Rooney JF; Gilead Sciences, Foster City, CA, USA.
Podlekareva D; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Respiratory Medicine and Infectious Disease, Copenhagen University Hospital, Bispebjerg, Denmark; Gilead Sciences, Foster City, CA, USA.
Mocroft A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Kirk O; Research Unit of Infectious Diseases, Department of Clinical Research, University of Southern Denmark, Odense, Denmark; CHIP, Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Pokaż więcej
Corporate Authors:: RESPOND Study group
Źródło:: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Oct; Vol. 147, pp. 107199. Date of Electronic Publication: 2024 Aug 13.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/epidemiology
Tuberculosis*/epidemiology
Humans ; Male ; Female ; Adult ; Risk Factors ; Europe/epidemiology ; Incidence ; Middle Aged ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/adverse effects ; CD4 Lymphocyte Count ; Cohort Studies

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 11.

Tytuł:: Ensuring People Living with HIV Inform the Future of HIV Treatment in Low- and Middle-Income Countries: A Scoping Review and Recommendations for a Community-Led Research Agenda.
Autorzy:: Resar DF; Clinton Health Access Initiative, 383 Dorchester Ave, Boston, MA, 02127, USA. .
Sapire R; Clinton Health Access Initiative, 383 Dorchester Ave, Boston, MA, 02127, USA.
Caldwell B; Clinton Health Access Initiative, 383 Dorchester Ave, Boston, MA, 02127, USA.
Jenkins S; Clinton Health Access Initiative, 383 Dorchester Ave, Boston, MA, 02127, USA.
Sikwese K; Afrocab, Lusaka, Zambia.
Wambui J; Afrocab, Lusaka, Zambia.
Nzano B; Clinton Health Access Initiative, 383 Dorchester Ave, Boston, MA, 02127, USA.
Amole C; Clinton Health Access Initiative, 383 Dorchester Ave, Boston, MA, 02127, USA.; Pokaż więcej
Źródło:: AIDS and behavior [AIDS Behav] 2024 Oct; Vol. 28 (10), pp. 3437-3448. Date of Electronic Publication: 2024 Jul 11.
Typ publikacji:: Journal Article; Review
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/epidemiology
Developing Countries*
COVID-19*/epidemiology
Humans ; SARS-CoV-2 ; Delivery of Health Care/organization & administration ; Anti-HIV Agents/therapeutic use

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 12.

Tytuł:: Peripheral neuropathy and associated factors among children living with HIV on antiretroviral therapy in Gamo zone, Southern Ethiopia: an institution-based cross-sectional study.
Autorzy:: Wondmagegn H; Department of Human Anatomy, College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia.
Birhanu A; Department of Human Anatomy, College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia. .
Gebremickael A; Department of Human Anatomy, College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia.
Esubalew H; School of Public Health, College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia.
Birhanu M; School of Medicine, College of Medicine and Health Science, Arba Minch University, Arba Minch, Ethiopia.
Gembe M; Department of Nursing, College of Health Science, Mattu University, Mattu, Ethiopia.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Sep 27; Vol. 24 (1), pp. 1059. Date of Electronic Publication: 2024 Sep 27.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/complications
HIV Infections*/epidemiology
Peripheral Nervous System Diseases*/epidemiology
Peripheral Nervous System Diseases*/chemically induced
Humans ; Ethiopia/epidemiology ; Cross-Sectional Studies ; Male ; Female ; Adolescent ; Child ; Child, Preschool ; Prevalence ; Risk Factors ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Mobile Phones and HIV Testing: Multicountry Instrumental Variable Analysis From Sub-Saharan Africa.
Autorzy:: Iacoella F; UNICEF Evaluation Office, New York, NY, United States.
Tirivayi N; UNICEF Innocenti-Global Office of Research and Foresight, Florence, Italy.; Pokaż więcej
Źródło:: Journal of medical Internet research [J Med Internet Res] 2024 Sep 27; Vol. 26, pp. e48794. Date of Electronic Publication: 2024 Sep 27.
Typ publikacji:: Journal Article
MeSH Terms:: Cell Phone*/statistics & numerical data
HIV Infections*/diagnosis
HIV Infections*/prevention & control
Humans ; Africa South of the Sahara ; Female ; Adult ; HIV Testing/methods ; HIV Testing/statistics & numerical data ; Young Adult ; Middle Aged

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 14.

Tytuł:: An optimized strategy triggered at the 2nd immunization visit to prevent HIV acquisition by breastfeeding: a phase 2 trial in Burkina Faso (PREVENIR-PEV).
Autorzy:: Mennecier A; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, 60 Rue de Navacelles, Montpellier, EFS, 34394, France. .
Sakana BLD; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.
D'Ottavi M; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, 60 Rue de Navacelles, Montpellier, EFS, 34394, France.
Tassembedo S; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.
Moles JP; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, 60 Rue de Navacelles, Montpellier, EFS, 34394, France.
Kania D; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.
Taofiki AO; Sexual and Reproductive Health Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.
Kadeba FE; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.
Diallo I; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.
Eymard-Duvernay S; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, 60 Rue de Navacelles, Montpellier, EFS, 34394, France.
Meda N; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.
Mosqueira B; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, 60 Rue de Navacelles, Montpellier, EFS, 34394, France.
Fao P; Infectious Disease Research Programme, Centre MURAZ/National Institute of Public Health, Bobo-Dioulasso, Burkina Faso.
Nagot N; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, 60 Rue de Navacelles, Montpellier, EFS, 34394, France.
Vande Perre P; Pathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, 60 Rue de Navacelles, Montpellier, EFS, 34394, France.; Pokaż więcej
Corporate Authors:: PREVENIR-PEV Study Group
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Sep 20; Vol. 24 (1), pp. 1014. Date of Electronic Publication: 2024 Sep 20.
Typ publikacji:: Journal Article; Clinical Trial, Phase II
MeSH Terms:: HIV Infections*/prevention & control
HIV Infections*/transmission
Breast Feeding*
Infectious Disease Transmission, Vertical*/prevention & control
Humans ; Burkina Faso ; Female ; Infant ; Adult ; Infant, Newborn ; Young Adult ; Adolescent ; Male ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/administration & dosage ; Viral Load ; Lamivudine/therapeutic use ; Lamivudine/administration & dosage ; Mothers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines.
Autorzy:: Schwarzmüller M; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Lozano C; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Schanz M; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Abela IA; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Grosse-Holz S; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Epp S; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Curcio M; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Greshake J; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Rusert P; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Huber M; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
Kouyos RD; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Günthard HF; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, 8091 Zurich, Switzerland.
Trkola A; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland. Electronic address: .; Pokaż więcej
Corporate Authors:: Swiss HIV Cohort Study
Źródło:: Cell reports. Medicine [Cell Rep Med] 2024 Sep 17; Vol. 5 (9), pp. 101702. Date of Electronic Publication: 2024 Aug 30.
Typ publikacji:: Journal Article
MeSH Terms:: HIV-1*/immunology
HIV-1*/drug effects
HIV Infections*/drug therapy
HIV Infections*/immunology
HIV Infections*/virology
HIV Infections*/blood
HIV Antibodies*/immunology
HIV Antibodies*/blood
Antibodies, Neutralizing*/immunology
Antibodies, Neutralizing*/blood
AIDS Vaccines*/immunology
AIDS Vaccines*/therapeutic use
Humans ; Anti-Retroviral Agents/therapeutic use ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/pharmacology ; Broadly Neutralizing Antibodies/immunology ; Broadly Neutralizing Antibodies/therapeutic use ; Neutralization Tests/methods

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 16.

Tytuł:: A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations.
Autorzy:: Biba C; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Fiaschi L; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Varasi I; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Paletti C; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Bartolini N; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Zazzi M; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Vicenti I; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.
Saladini F; Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Sep 14; Vol. 16 (9). Date of Electronic Publication: 2024 Sep 14.
Typ publikacji:: Journal Article; Comparative Study
MeSH Terms:: HIV-1*/genetics
HIV-1*/drug effects
Drug Resistance, Viral*/genetics
High-Throughput Nucleotide Sequencing*/methods
HIV Infections*/virology
HIV Infections*/drug therapy
Mutation*
Humans ; Male ; Female ; Anti-HIV Agents/pharmacology ; Anti-HIV Agents/therapeutic use ; Genotype ; Adult ; Middle Aged ; RNA, Viral/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Formalized peer referral to HIV pre-exposure prophylaxis supported with self-testing: a mixed-methods pilot study among young Kenyan women.
Autorzy:: McGowan M; Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.; School for Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
Wairimu N; Partners in Health and Research Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Reedy AM; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Mogere P; Partners in Health and Research Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Culquichicon C; Department of Epidemiology, University of Washington, Seattle, WA, United States.
Njeru I; Partners in Health and Research Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Malen RC; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Jahn A; Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.
Bärnighausen T; Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany.; Harvard Center for Population and Development Studies, Cambridge, MA, United States.; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Roche SD; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Ngure K; School of Public Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.; Department of Global Health, University of Washington, Seattle, WA, United States.
Ortblad KF; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.; Pokaż więcej
Źródło:: Frontiers in public health [Front Public Health] 2024 Sep 11; Vol. 12, pp. 1428609. Date of Electronic Publication: 2024 Sep 11 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Pre-Exposure Prophylaxis*
HIV Infections*/prevention & control
HIV Infections*/diagnosis
Peer Group*
Referral and Consultation*
Self-Testing*
Humans ; Female ; Kenya ; Pilot Projects ; Adolescent ; Young Adult ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/administration & dosage

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 18.

Tytuł:: Characteristics of and Factors Associated With Partner Service Uptake Cascade Among People With Newly Reported HIV/AIDS Diagnoses in Southeastern China in 2022: Cross-Sectional Survey.
Autorzy:: Jiang J; Zhejiang Provincial Center for Disease and Control and Prevention, Hangzhou, China.
Chen L; Zhejiang Provincial Center for Disease and Control and Prevention, Hangzhou, China.
Cheng W; Zhejiang Provincial Center for Disease and Control and Prevention, Hangzhou, China.
Chen W; Zhejiang Provincial Center for Disease and Control and Prevention, Hangzhou, China.
Yang J; Zhejiang Provincial Center for Disease and Control and Prevention, Hangzhou, China.
Xu Y; Zhejiang Provincial Center for Disease and Control and Prevention, Hangzhou, China.
Zhou X; Zhejiang Provincial Center for Disease and Control and Prevention, Hangzhou, China.
Pan X; Zhejiang Provincial Center for Disease and Control and Prevention, Hangzhou, China.
Chai C; Zhejiang Provincial Center for Disease and Control and Prevention, Hangzhou, China.; Pokaż więcej
Źródło:: JMIR public health and surveillance [JMIR Public Health Surveill] 2024 Sep 09; Vol. 10, pp. e59095. Date of Electronic Publication: 2024 Sep 09.
Typ publikacji:: Journal Article
MeSH Terms:: Contact Tracing*/methods
Contact Tracing*/statistics & numerical data
Sexual Partners*
HIV Infections*/epidemiology
HIV Infections*/diagnosis
Humans ; China/epidemiology ; Male ; Cross-Sectional Studies ; Female ; Adult ; Middle Aged ; Adolescent ; Young Adult ; HIV Testing/statistics & numerical data ; HIV Testing/methods ; Surveys and Questionnaires ; Acquired Immunodeficiency Syndrome/epidemiology

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 19.

Tytuł:: Unveiling the prevalence of anaemia and its predictors among adults on highly active antiretroviral therapy in the dolutegravir era: a retrospective cross-sectional study.
Autorzy:: Sisay Zewdu W; School of Pharmacy Department of Pharmacology and Toxicology, Debre Tabor University, Debre Tabor, Ethiopia .
Molla Zeleke M; School of Pharmacy Department of Pharmacology and Toxicology, Debre Tabor University, Debre Tabor, Ethiopia.
Ferede YA; School of Pharmacy Department of Pharmacology and Toxicology, Debre Tabor University, Debre Tabor, Ethiopia.
Kassie AB; School of Pharmacy Department of Pharmacology and Toxicology, Debre Tabor University, Debre Tabor, Ethiopia.
Singh P; Department of Pharmaceutical Chemistry, Debre Tabor University, Debre Tabor, Ethiopia.
Alemu MA; School of Pharmacy Department of Pharmacology and Toxicology, Debre Tabor University, Debre Tabor, Ethiopia.
Desta GT; School of Pharmacy Department of Pharmacology and Toxicology, Debre Tabor University, Debre Tabor, Ethiopia.; Pokaż więcej
Źródło:: BMJ open [BMJ Open] 2024 Sep 05; Vol. 14 (9), pp. e086480. Date of Electronic Publication: 2024 Sep 05.
Typ publikacji:: Journal Article
MeSH Terms:: Anemia*/epidemiology
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Antiretroviral Therapy, Highly Active*
Oxazines*
Pyridones*/therapeutic use
Heterocyclic Compounds, 3-Ring*/therapeutic use
Humans ; Female ; Male ; Adult ; Cross-Sectional Studies ; Retrospective Studies ; Ethiopia/epidemiology ; Prevalence ; Middle Aged ; Risk Factors ; CD4 Lymphocyte Count ; Young Adult ; HIV Integrase Inhibitors/therapeutic use ; Severity of Illness Index ; Piperazines

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Skocz do pozycji: 20.

Tytuł:: Pioneering cord blood transplantation in relapsed/refractory HIV-related lymphoma: a case study with concurrent intramuscular antiretroviral therapy.
Autorzy:: Yokota T; Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
Kurosawa S; Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan. Electronic address: .
Yoshimura Y; Division of Infectious Disease, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
Bingo M; Department of Laboratory Medicine, Tokyo Medical University Hospital, Shinjuku, Tokyo, Japan.
Yamaguchi T; Department of Laboratory Medicine, Tokyo Medical University Hospital, Shinjuku, Tokyo, Japan.
Takada Y; Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
So Y; Division of Infectious Disease, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
Miyata N; Division of Infectious Disease, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
Nakayama H; Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
Sakurai A; Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
Sato K; Division of Infectious Disease, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
Ito C; Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
Aisa Y; Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.
Nakazato T; Department of Hematology, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan.; Pokaż więcej
Źródło:: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Sep; Vol. 146, pp. 107124. Date of Electronic Publication: 2024 Jun 04.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Cord Blood Stem Cell Transplantation*/adverse effects
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/therapy
HIV Infections*/drug therapy
HIV Infections*/complications
Humans ; Male ; Adult ; Lymphoma, AIDS-Related/drug therapy ; Lymphoma, AIDS-Related/therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Injections, Intramuscular ; Prednisone/therapeutic use ; Prednisone/administration & dosage ; Doxorubicin/therapeutic use ; Doxorubicin/administration & dosage ; Vincristine/therapeutic use ; Vincristine/administration & dosage ; Cyclophosphamide/therapeutic use ; Cyclophosphamide/administration & dosage ; Rituximab/therapeutic use ; Rituximab/administration & dosage ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/administration & dosage ; Anti-Retroviral Agents/therapeutic use ; Anti-Retroviral Agents/administration & dosage

Czasopismo naukowe

na półce

Full Text Finder Szczegóły

Informacja

Wyszukujesz frazę ""HIV"" wg kryterium: Temat